Table 1.
Demographic and clinical characteristics of patients with hepatocellular carcinoma for the study of tissue lncRNAs expression n (%)
| Parameters | Description | Minimum | Maximum |
| Age (yr) | 56.59 ± 10.97 | 30 | 73 |
| Gender | |||
| Male | 26 (89.70) | ||
| Female | 3 (10.30) | ||
| Hepatitis virus infection | |||
| HBV | 22 (75.90) | ||
| HCV | 3 (10.30) | ||
| Negative | 4 (13.80) | ||
| Tumor size (cm) | 6.44 ± 3.65 | 2 | 19 |
| Tumor differentiation | |||
| Well | 6 (20.70) | ||
| Moderate | 16 (55.20) | ||
| Poor | 7 (24.10) | ||
| TNM stage | |||
| I | 10 (34.50) | ||
| II | 11 (37.90) | ||
| III | 7 (14.0) | ||
| IV | 1 (3.40) | ||
| BCLC stage | |||
| A | 21 (72.40) | ||
| B | 1 (3.40) | ||
| C | 7 (24.10) | ||
| AFP (ng/mL) | |||
| ≤ 400 | 17 (58.60) | ||
| > 400 | 12 (41.40) | ||
| PVTT | |||
| Present | 23 (79.30) | ||
| Absent | 6 (20.70) | ||
| Tumor number | |||
| Single | 27 (93.10) | ||
| Multiple | 2 (6.90) | ||
| Capsule invasive | |||
| Present | 6 (20.70) | ||
| Absent | 23 (79.30) | ||
| ALP (U/L) | 42.90 ± 32.24 | 11 | 159 |
| ALB (g/L) | 39.86 ± 3.72 | 28 | 47 |
| TBIL (μmol/L) | 15.36 ± 7.41 | 7.1 | 42.6 |
| DBIL (μmol/L) | 6.10 ± 3.08 | 3 | 16.5 |
Data are expressed as mean ± SD or n (%). TNM: Tumor-node-metastasis staging system; BCLC: The Barcelona Clinic Liver Cancer staging system; HBV: Hepatitis B virus; HCV: Hepatitis C virus; AFP: Alpha fetoprotein; PVTT: Portal vein tumor thrombus; ALP: Alkaline phosphatase; ALB: Albumin; TBIL: Total bilirubin; DBIL: Direct bilirubin.